Key result
Balanced turbo field echo (bTFE) produced significantly better image quality and venous suppression (P < 0.001) and higher SNR and CNR (P < 0.05) compared to MOTSA.
Why the study?
Does balanced turbo field echo (bTFE) improve image quality and stenosis depiction compared to MOTSA and CE-MRA in patients with cerebrovascular disease?
Cross-Sectional (n=86)
Blinded
Does balanced turbo field echo (bTFE) improve image quality and stenosis depiction compared to MOTSA and CE-MRA in patients with cerebrovascular disease?
bTFE is a robust, faster alternative or adjunct to MOTSA that provides high-quality images with enhanced SNR and CNR for evaluating mild to moderate carotid artery stenosis.
bTFE may enhance carotid MRA quality over MOTSA; leaves open its role versus CE-MRA in stenosis assessment.
PURPOSE: To compare balanced turbo field echo (bTFE) with multiple overlapping thin slice acquisition (MOTSA) and contrast-enhanced MR angiography (CE-MRA) in depicting carotid artery stenosis. MATERIALS AND METHODS: In this study 86 patients with cerebrovascular disease, who had been referred for a carotid examination, were imaged. All of the patients underwent MOTSA and one of four bTFE sequences followed by CE-MRA. Formatted maximum intensity projections (MIPs) and source images were read in a blinded fashion by a radiologist. Inter- and intrasequence statistical analyses were performed. RESULTS: We first compared image quality (IQ) and fat, background, and venous suppression using four distinct bTFE protocols in 118 carotid arteries, and found that bTFE4 performed the best. We then compared IQ, grades of stenosis, and background and venous suppression among bTFE4, MOTSA, and CE-MRA. bTFE produced significantly better IQ and venous suppression (P < 0.001), and higher SNR and CNR (P < 0.05) when compared to MOTSA. CONCLUSION: The bTFE sequence is robust and provides high-quality images in patients with mild to moderate carotid artery stenosis. Even though there is a tendency to overestimate stenosis with bTFE compared to CE-MRA, the shorter scan time of bTFE coupled with enhanced SNR and CNR measurements validates it as a clinically useful adjunct to MOTSA, if not a replacement.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2005) conducted a cross-sectional in Cerebrovascular disease (n=86). Balanced turbo field echo (bTFE) vs. Multiple overlapping thin slice acquisition (MOTSA) and contrast-enhanced MR angiography (CE-MRA) was evaluated on Image quality and venous suppression (p=< 0.001). Balanced turbo field echo (bTFE) produced significantly better image quality and venous suppression (P < 0.001) and higher SNR and CNR (P < 0.05) compared to MOTSA.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: